Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
about
Autoantibodies with enzymatic properties in human autoimmune diseases.Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.Inhibitor development.Varied immune response to FVIII: presence of proteolytic antibodies directed to factor VIII in different human pathologies.Characteristics, mechanisms of action, and epitope mapping of anti-factor VIII antibodies.Diagnosis and quantification of factor VIII inhibitors.Toward effective HIV vaccination: induction of binary epitope reactive antibodies with broad HIV neutralizing activity.Acquired hemophilia A: a frequently overlooked autoimmune hemorrhagic disorder.Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?A close insight to factor VIII inhibitor in the congenital hemophilia A.Deoxyribonuclease activity of polyclonal IgGs: a putative serological marker in patients with spondyloarthritides.Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.Persistent factor VIII inhibitors and orthopaedic complications in children with severe haemophilia A.Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research.Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitors.Catalytic antibodies in patients with systemic lupus erythematosus
P2860
Q35214200-2BB4B422-1BF7-4332-A9B6-1C682D6D8C2DQ35880109-3D1E5115-1AB0-477F-9D1F-76882CFA3156Q36707550-2C6A8DE6-3260-4E2D-8766-BEF1C2DBFC37Q36905946-4EC6F199-22D1-4444-9774-C40F1EE631A8Q37031556-DDF9DE5D-221E-469A-BBF7-57ED7213B871Q37176486-9A4C0DA4-D726-44D1-90C9-E657AAFF5899Q37374547-4C8DCBE1-1756-4261-A37F-1C03E8AF7FC4Q37378510-06D543F7-2444-4C1A-9048-D20BF6A2CB5BQ37396497-C5DFEAE6-5619-43B7-8017-B905DD4906D7Q37431843-E368C932-684B-41DF-B1DE-5D6012AF35BDQ37704765-F6423B87-4917-418F-90E9-84B57CD531D5Q37944291-292265F6-3D07-4CAE-876F-D8DC2C83D4FAQ38883211-56AAA099-2395-428A-9332-54D3001DB34EQ42266445-E7875F62-2517-40EA-BE77-E98FA4019095Q45865139-B23D5719-E9BC-423D-B5B3-EF166D09356BQ45867897-530D40E1-D284-47F1-924A-A9AFDA6AFE83Q45882703-128790F8-0826-4FDB-899F-1F53227391F7Q45883602-CAC63BE0-71E3-44C1-8CA8-2831276D9916Q58796857-E7F0AC16-3F40-4E8D-80F3-8FC97BF01775
P2860
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
@en
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
@nl
type
label
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
@en
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
@nl
prefLabel
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
@en
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII.
@nl
P2093
P50
P921
P1476
Catalytic IgG from patients with hemophilia A inactivate therapeutic factor VIII
@en
P2093
Alain Friboulet
Bharath Wootla
Evgueni Saenko
Johan Hoebeke
Joseph Reinbolt
Michel D Kazatchkine
Sandrine Delignat
Srini V Kaveri
Suryasarathi Dasgupta
Valakunja Nagaraja
P304
P356
10.4049/JIMMUNOL.177.2.1355
P407
P577
2006-07-01T00:00:00Z